USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Bionique Laboratorytories I
Address:
Bloomingdale Road
Saranac Lake, NY 12983
Phone:
(518) 891-2356
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $105,974.00 2
SBIR Phase II $444,474.00 2

Award List:

RAPID IDENTIFICATION OF MYCOPLASMAS WITH IMMUNOENZYMES

Award Year / Program / Phase:
1983 / SBIR / Phase I
Award Amount:
$56,000.00
Agency:
HHS
Principal Investigator:
Michael C. Gabridge Ph.d.
Abstract:
N/a

RAPID IDENTIFICATION OF MYCOPLASMAS WITH IMMUNOENZYMES

Award Year / Program / Phase:
1984 / SBIR / Phase II
Award Amount:
$294,276.00
Agency:
HHS
Principal Investigator:
Michael C. Gabridge Ph.d.
Abstract:
The project which we propose is designed to examine the technical feasibility of a new type of identification systemfor mycoplasmas. mycoplasmas, bacteria-like microbes which cause human and animal disease and contaminate cell culturesare ubiquitous. they must be identified to the genus and species… More

DEVELOPMENT OF A DNA PROBE FOR THE RAPID DETECTION OF OF MYCOMPLASMA GALLISEPTICUM

Award Year / Program / Phase:
1985 / SBIR / Phase I
Award Amount:
$49,974.00
Agency:
USDA
Principal Investigator:
Abstract:
N/a

DEVELOPMENT OF A DNA PROBE FOR THE RAPID DETECTION OF OF MYCOMPLASMA GALLISEPTICUM

Award Year / Program / Phase:
1986 / SBIR / Phase II
Award Amount:
$150,198.00
Agency:
USDA
Principal Investigator:
Abstract:
The objective of this project is to construct a mycomplasma gallisepticum biotinylated dna probe. economic losses from m. gallisepticum infection are estimated to be $118 million annually in the united states. minimum efficiency of m. gallisepticum disease control requires a rapid and… More